Cargando…
Pelvic MRI, FDG-PET/CT, and Somatostatin Receptor Scintigraphy Findings of Treatment-Related Neuroendocrine-Differentiated Prostate Cancer
Treatment-related neuroendocrine-differentiated prostate cancer (NEPC) is a rare tumor entity that transdifferentiates from adenocarcinoma as an adaptive response to androgen receptor pathway inhibition. We report a 79-year-old male with treatment-related NEPC, presenting as rectal bleeding after ho...
Autores principales: | Kitajima, Kazuhiro, Yamamoto, Shingo, Ikeda, Masataka, Yamasaki, Takashi, Kawanaka, Yusuke, Komoto, Hisashi, Maruyama, Mitsunari, Nishizaki, Kosuke, Kimura, Kei, Kimura, Neinei, Yamakado, Koichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983583/ https://www.ncbi.nlm.nih.gov/pubmed/33776735 http://dx.doi.org/10.1159/000511070 |
Ejemplares similares
-
MRI Finding of Prostatic Ductal Adenocarcinoma
por: Kitajima, Kazuhiro, et al.
Publicado: (2021) -
CT Findings of Primary Renal Angiosarcoma
por: Komoto, Hisashi, et al.
Publicado: (2021) -
Tiny Obturator Node Metastasis from Prostate Cancer Not Shown by FDG-PET/CT, CT, or MRI Detected by (11)C-Choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2018) -
Detection of Abdominal Lymph Node Metastasis from Pancreatic Neuroendocrine Tumor by Somatostatin Receptor Scintigraphy: Comparison with Somatostatin Receptor Type 2 Immunostaining
por: Kitajima, Kazuhiro, et al.
Publicado: (2023) -
Somatostatin receptor scintigraphy in the follow up of neuroendocrine neoplasms of appendix
por: Saponjski, Jelena, et al.
Publicado: (2020)